Adaptive Biotechnologies

About:

Adaptive Biotechnologies translates scale and precision of the adaptive immune system into products to diagnose and treat disease.

Website: http://adaptivebiotech.com

Twitter/X: Adaptivebiotech

Top Investors: OrbiMed, Viking Global Investors, ARK Investment Management, EquityZen, Rock Springs Capital

Description:

Adaptive Biotechnologies is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clone-SEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. It was founded in 2009 and headquartered in Seattle, Washington.